Correlation Between Protagenic Therapeutics and Agenus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Agenus Inc, you can compare the effects of market volatilities on Protagenic Therapeutics and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Agenus.

Diversification Opportunities for Protagenic Therapeutics and Agenus

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Protagenic and Agenus is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Agenus go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and Agenus

Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 1.01 times more return on investment than Agenus. However, Protagenic Therapeutics is 1.01 times more volatile than Agenus Inc. It trades about 0.0 of its potential returns per unit of risk. Agenus Inc is currently generating about -0.05 per unit of risk. If you would invest  208.00  in Protagenic Therapeutics on August 26, 2024 and sell it today you would lose (143.00) from holding Protagenic Therapeutics or give up 68.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Protagenic Therapeutics  vs.  Agenus Inc

 Performance 
       Timeline  
Protagenic Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Protagenic Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Agenus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Protagenic Therapeutics and Agenus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protagenic Therapeutics and Agenus

The main advantage of trading using opposite Protagenic Therapeutics and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.
The idea behind Protagenic Therapeutics and Agenus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios